argenx Management to Present at Upcoming Virtual Investor Conferences
02 Setembro 2020 - 2:00AM
September 2, 2020 Breda, the Netherlands
/ Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases and cancer, today
announced that members of management will participate in several
upcoming conferences:
- Baird Global Healthcare Conference. Fireside chat on Wednesday,
September 9, 2020 at 12:15 p.m. ET.
- Morgan Stanley Global Healthcare Conference. Fireside chat on
Monday, September 14, 2020 at 1:30 p.m. ET.
- BofA Global Healthcare Conference. Fireside chat on Thursday,
September 17, 2020 at 10:50 a.m. BST.
- Stifel Immunology & Inflammation Summit. Panel on Thursday,
October 1, 2020 at 11:00 a.m. ET.
Additional information regarding these events
will be available on the Company’s website at www.argenx.com.
About argenxargenx is a global
immunology company committed to improving the lives of people
suffering from severe autoimmune diseases and cancer. Partnering
with leading academic researchers through its Immunology Innovation
Program (IIP), argenx is translating immunology breakthroughs into
a world-class portfolio of novel antibody-based medicines. argenx
is evaluating efgartigimod in multiple serious autoimmune diseases,
and cusatuzumab in hematological cancers in collaboration with
Janssen. argenx is also advancing several earlier stage
experimental medicines within its therapeutic franchises. argenx
has offices in Belgium, the United States and Japan. For more
information, visit www.argenx.com and follow us on LinkedIn at
https://www.linkedin.com/company/argenx/.
For further information, please contact:
Beth DelGiacco, Vice President, Investor Relations (US)+1 518
424 4980bdelgiacco@argenx.com
Joke Comijn, Director Corporate Communications & Investor
Relations (EU)+32 (0)477 77 29 44+32 (0)9 310 34
19jcomijn@argenx.com
Argen X (EU:ARGX)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Argen X (EU:ARGX)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024